Verona Pharma Plc (VRNA) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access VRNA Annual Balance Sheets →
Reviewing balance sheet data across recent quarters allows users to assess how Verona Pharma Plc manages assets, liabilities, and equity through different cycles.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2025)
(Mar 31 2025) (Dec 31 2024) (Sep 30 2024) (Jun 30 2024)
Assets
Cash & cash equivalent438.02
Cash & Short-term Investments438.00
Accounts receivable82.86
Inventories8.61
Other Current Assets7.93
Prepaid Expense, Current AS11.43
Total Current Assets548.85
Equipment/Property/Plant Net0.99
Goodwill net0.55
Tax Assets, Noncurrent0.00
Other Assets, Noncurrent22.48
Tax Credit And Income Taxes Receivable Current4.06
Operating Lease Right Of Use Asset1.57
Total Assets572.87
Liabilities
Accounts Payable, Current AC3.43
Accrued Liabilities, Current AC21.80
Other Liabilities, Current4.48
Taxes Payable, Current, Total0.00
Total Current Liabilities51.24
Long-term debt242.43
Total Long-term Debt242.43
Accrued Income Taxes, Noncurrent0.00
Other liabilities, Noncurrent22.45
Operating Lease Liability Current1.01
Operating Lease Liability Noncurrent0.93
Total Liabilities294.60
Stockholders' Equity
Common Stock Value45.02
Treasury Stock Value-0.96
Additional Paid In Capital Common Stock805.92
Retained Earnings / Accumulated Deficit-567.10
Accumulated Other Comprehensive Income-4.60
Other Equity-4.60
Common Stockholder's Equity278.27
Total Stockholder's Equity278.27
Liabilities & Stockholder's Equity572.87
4 historic quarters locked

Sign in to unlock the full Verona Pharma Plc balance sheet history.

About Verona Pharma Plc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001657312-25-000026

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.